Remote delivery of a weight management intervention for adults with intellectual disabilities: Results from a randomized non-inferiority trial

Disabil Health J. 2024 Apr;17(2):101587. doi: 10.1016/j.dhjo.2024.101587. Epub 2024 Jan 22.

Abstract

Background: Remote delivery of multi-component weight management interventions results in clinically meaningful weight loss in adults without intellectual disabilities (ID), but the effectiveness of remotely delivered weight management interventions in adults with ID has not previously been evaluated.

Objective: To determine if a weight management intervention delivered remotely could achieve weight loss (kg) at 6 months that is non-inferior to in-person visits in adults with ID and overweight or obesity (BMI ≥25 kg/m2).

Methods: Participants were randomized to a 24-mo. trial (6 mos weight loss,12 mos weight maintenance, 6 mos. no-contact follow up) to compare weight loss achieved with the same multicomponent intervention delivered to individual participants in their home either remotely (RD) or during face-to-face home visits (FTF).

Results: One hundred twenty adults with ID (∼32 years of age, 53 % females) were randomized to the RD (n = 60) or the FTF arm (n = 60). Six-month weight loss in the RD arm (-4.9 ± 7.8 kg) was superior to 6-month weight loss achieved in the FTF arm (-2.1 ± 6.7 kg, p = 0.047). However, this may be partially attributed to the COVID-19 pandemic, since weight loss in the FTF arm was greater in participants who completed the intervention entirely pre-COVID (n = 33,-3.2 %) compared to post-COVID (n = 22, -0.61 %). Weight loss across did not differ significantly between intervention arms at 18 (p = 0.33) or 24 months (p = 0.34).

Conclusion: Our results suggest that remote delivery is a viable option for achieving clinically relevant weight loss and maintenance in adults with ID.

Nct registration: NCT03291509.

Keywords: Diet; Down syndrome; Technology; Weight loss; Weight maintenance.

Publication types

  • Randomized Controlled Trial
  • Equivalence Trial

MeSH terms

  • Adult
  • Disabled Persons*
  • Female
  • Humans
  • Intellectual Disability* / complications
  • Male
  • Middle Aged
  • Obesity / epidemiology
  • Obesity / therapy
  • Pandemics
  • Weight Loss

Associated data

  • ClinicalTrials.gov/NCT03291509